Treatment Resistant Cancers
Targeted Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 6, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Paula Aristizabal1, Luke Burns, Rebeca Rivera-Gomez
1*Department of Pediatrics, Division of Pediatric Hematology/Oncology ‡Reducing Cancer Disparities Program #Moores Cancer Center §School of Medicine ¶Department of Neurosurgery, Division of Pediatric Neurosurgery **Department of Neurosciences, University of California, San Diego, La Jolla †Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital San Diego, San Diego, CA ∥Hospital General de Tijuana, Universidad Autonoma de Baja California, Tijuana, Baja California, Mexico.
A tailored treatment for infant medulloblastoma in resource-limited settings avoided radiation and high-dose cisplatin. This approach led to remission, offering a viable alternative for similar cases globally.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: